Do women lead, connect and share differently? Subscribe for the latest stories.

Newborn infants experience psychiatric drug withdrawal

Source:

Babies born to women with psychotic disorders often have the deck stacked against them. Their mothers tend to receive less prenatal care; have poorer nutrition; use more tobacco, alcohol, and illicit drugs; are unlikely to be married; and often have limited social support. New labeling recently promulgated by the Food and Drug Administration (FDA) warns that these babies may also be susceptible to withdrawal symptoms from their mothers’ antipsychotic medications, but some practitioners fear the results of those warnings will be worse than the symptoms of withdrawal.

Last month the FDA posted a Safety Alert for Human Medical Products notifying health care professionals that the pregnancy section of drug labels for the entire class of antipsychotic drugs has been updated. The new drug labels contain more and consistent information about the potential risk for extrapyramidal symptoms (EPS) and withdrawal symptoms in newborns whose mothers were treated with antipsychotic medications during the third trimester of pregnancy. Drugs receiving the warning include Haldol, FazaClo, Fanapt, Clozaril, Risperdal, Zyprexa, Seroquel, Abilify, Geodon, Invega, Loxitane, Moban, Navane, Orap, Saphris, Stelazine, Thorazine, and the olanzapine-fluoxetine combination known as Symbyax and are primarily used in the treatment of schizophrenia and bipolar disorder.





    • Very interesting article. Message is a bit shocking to me. But good to know

-->

Read the world's local women's news


How does Femina work?

  • Step 1
    1
    Local Country Editors From Around the World
  • Step 2
    2
    Choose News Articles From Their Countries’ Local Language Papers
  • Step 3
    3
    Summarize & Contextualize The Stories In English

Got it!

Swipe for more Top Stories


Got it!